# Vaxart, Inc.: Form 8-K, filed Jan 16, 2024

- Company: [Vaxart, Inc.](/companies/vxrt.md) (CIK 72444)
- Form: 8-K
- Filed: 2024-01-16
- Accepted by EDGAR: Jan 16, 2024, 09:19 ET
- Period: 2024-01-15
- Accession: 0001437749-24-001326
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/72444/000143774924001326/vxrt20240115_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/72444/000143774924001326/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/72444/000143774924001326/vxrt20240115_8k.htm

Filed Jan 16, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-001326. Last ingested by Listed: Nov 5, 2026, 18:48 ET. No prices; not investment advice.